Keywords: رد شد; Bosutinib; Tyrosine kinase inhibitors; Pleural effusions; Pulmonary arterial hypertension; Interstitial lung disease;
مقالات ISI رد شد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رد شد; Leukemia; Myelogenous; Chronic; BCR-ABL Positive; Bosutinib;
Keywords: رد شد; Bosutinib; Dasatinib; Nilotinib; Ponatinib; Radotinib
Keywords: رد شد; Chronic myeloid leukemia; Tyrosine kinase inhibitors; Imatinib; Dasatinib; Nilotinib; Bosutinib; Ponatinib;
Ascending Single-Dose Study of the Safety Profile, Tolerability, and Pharmacokinetics of Bosutinib Coadministered With Ketoconazole to Healthy Adult Subjects
Keywords: رد شد; bosutinib; ketoconazole; pharmacokinetics; tyrosine kinase inhibitor;
Optimizing the Use of TKIs in the Management of Chronic Myelogenous Leukemia
Keywords: رد شد; Bosutinib; Chronic myelogenous leukemia; Dasatinib; Imatinib; Nilotinib; Tyrosine kinase inhibitor
Les nouveaux médicaments de la cancérologie
Keywords: رد شد; antinéoplasique; bosutinib; inhibiteur de tyrosine kinase; régorafénib; thérapie ciblée; vismodegibantineoplastics; bosutinib; regorafenib; targeted therapy; tyrosine kinase inhibitor; vismodegib
The dissociation constants of the cytostatic bosutinib by nonlinear least-squares regression of multiwavelength spectrophotometric and potentiometric pH-titration data
Keywords: رد شد; Dissociation constants; Bosutinib; Spectrophotometric titration; Potentiometric Titration; SQUAD(84) SPECFIT/32; ESAB2M; HYPERQUAD; INDICES; PALLAS
A simple method for the determination of Bosutinib in rat plasma by UPLC-MS/MS
Keywords: رد شد; Bosutinib; Rat; UPLC-MS/MS; Plasma; Pharmacokinetics
Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL+ leukemia cells
Keywords: رد شد; CML, chronic myeloid leukemia; ALL, acute lymphoblastic leukemia; ERK, extracellular-signal-regulated kinases; MEK, mitogen-activated protein kinaseChronic myeloid leukemia; BCR/ABL; Bosutinib; Chk1 inhibitor
HPLC–DAD protein kinase inhibitor analysis in human serum
Keywords: رد شد; Vatalanib; Bosutinib; Canertinib; Tandutinib; Pazopanib; Erlotinib
Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia
Keywords: رد شد; Chronic phase; Chronic myeloid leukemia; Bosutinib; Health-related quality of life; FACT-Leu
STIM1 tyrosine-phosphorylation is required for STIM1-Orai1 association in human platelets
Keywords: رد شد; STIM1; Stromal interaction molecule 1; SOCE; operated Ca2+ entry mechanism; SERCA2b; sarco-endoplasmic Ca2+-ATPase isotype 2b; IP3R II; inositol trisphosphate receptor; TRPC; transient receptor potential channel; SKFs; Src family of tyrosine kinases; Btk;
What do kinase inhibition profiles tell us about tyrosine kinase inhibitors used for the treatment of CML?
Keywords: رد شد; Kinase inhibition profiles; BCR-ABL inhibitors; Chronic myeloid leukemia; Tyrosine kinase inhibitors; Imatinib; Nilotinib; Dasatinib; Bosutinib;
Une innovation thérapeutique : les inhibiteurs de tyrosine kinase de deuxième génération (ITK 2) dans le traitement de la LMC
Keywords: رد شد; LMC; imatinib; nilotinib; dasatinib; bosutinib; ITK 2; CML; imatinib; nilotinib; dasatinib; bosutinib; TKI 2;
Src Inhibitors in Lung Cancer: Current Status and Future Directions
Keywords: رد شد; Bosutinib; Dasatinib; EGFR; Saracatinib
The Src Family of Protein Tyrosine Kinases: A New and Promising Target for Colorectal Cancer Therapy
Keywords: رد شد; Bosutinib; Dasatinib; EGFR; Saracatinib; Src inhibitors; VEGF
First-line Therapy for Chronic Myeloid Leukemia: New Horizons and an Update
Keywords: رد شد; Bosutinib; Dasatinib; Imatinib; Nilotinib
Clinical Algorithms for the Treatment of Patients With Chronic Myeloid Leukemia: The 2010 Perspective
Keywords: رد شد; AP24534; BCR-ABL; Bosutinib; Dasatinib; Imatinib; Nilotinib; Omacetaxine
SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer
Keywords: رد شد; Prostate cancer; Breast cancer; SRC kinase; Bone metastases; SRC inhibitors; Dasatinib; Bosutinib; Saracatinib
Bosutinib: A review of preclinical studies in chronic myelogenous leukaemia
Keywords: رد شد; Bosutinib; SKI-606; Chronic myelogenous leukaemia; Src; Bcr-Abl; Breast cancer; Tumour; Tyrosine kinase inhibitor; Imatinib resistance; Clinical trials
Tailoring tyrosine kinase inhibitor therapy to tackle specific BCR-ABL1 mutant clones
Keywords: رد شد; CML; Imatinib; Nilotinib; Bosutinib; BCR-ABL1; Clones